What is Evogen?
Evogen, Inc. is a pioneering entity in the field of neurology, specializing in proteomics and genomics to advance precision medicine. The company offers innovative technologies for diagnostics, including reagent technology and biothreat detection. Key products like EvoScore and HyBeacons enable rapid and accurate identification of neurological diseases and pathogens. Evogen's mission is to address critical unmet medical needs, enhance treatment outcomes, and reduce healthcare expenditures. Their focus on improving clinical practices and patient care serves healthcare providers and life sciences researchers.
How much funding has Evogen raised?
Evogen has raised a total of $852K across 1 funding round:
Private Equity
$852K
Private Equity (2014): $852K, investors not publicly disclosed
What's next for Evogen?
The recent major strategic investment signals a pivotal growth phase for Evogen. This capital infusion is expected to accelerate the development and commercialization of its advanced diagnostic tools, further solidifying its position in the precision medicine and neurology markets. The company is poised to expand its technological capabilities and market reach, driving innovation in disease detection and treatment.
See full Evogen company page
